Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.4 (
trypsin
)
42,187
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The crystal structure of
trypsin
-modified elongation factor Tu from Escherichia coli, in complex with the cofactor guanosine diphosphate has been refined to a crystallographic R-factor of 19.3%, at 2.6 A resolution. In the model described, the root-mean-square deviation from ideality is 0.019 A for bond distances and 3.9 degrees for angles. The protein consists of three domains: an alpha/beta domain (residues 1 to 200), containing the binding site of the GDP cofactor, and consisting of a six-stranded beta-pleated sheet, six alpha-helices, and two all-beta domains (residues 209 to 299 and 300 to 393), belonging to the tertiary structural class of antiparallel beta-barrels. The GDP-binding domain has a folding that is found in other GDP-binding proteins.
Elongation factor Tu
interacts with proteins, nucleic acids and nucleotides, making this molecule well suited as a model system for the study of these interactions.
...
PMID:Refined structure of elongation factor EF-Tu from Escherichia coli. 154 16
Elongation factor Tu
from Thermus thermophilus was treated successively with periodate-oxidized GDP or GTP and cyanoborohydride. Covalently modified cyanogen bromide or
trypsin
fragments of the protein were isolated, and the position of their modification was determined. Lysine residues 52 and 137 were heavily labeled, lysine-137 being considerably more reactive in the GTP form as compared to the GDP form of the protein. These residues are in the proximity of the GDP/GTP binding site. Lys-325 was also labeled, but to a lower extent. The part of the EF-Tu containing residue 52 is missing in crystallized EF-Tu.GDP from Escherichia coli [Jurnak, F. (1985) Science (Washington, D.C.) 230, 32-36]. These results place the part of T. thermophilus EF-Tu corresponding to the missing fragment in E. coli EF-Tu in the vicinity of the nucleotide binding site and allow its role in the interaction with aminoacyl-tRNA and elongation factor Ts to be evaluated. Cross-linking of EF-Tu.GDP by irradiation at 257 nm showed that a sequence of 10 amino acids residues which is found in the Thermus thermophilus elongation factor Tu but not in other homologous bacterial proteins is located in the vicinity of the GDP/GTP binding site.
...
PMID:Affinity labeling of the GDP/GTP binding site in Thermus thermophilus elongation factor Tu. 324 17
The complete amino acid sequence of elongation factor Tu of Escherichia coli has been established by sequencing overlapping cyanogen bromide and tryptic peptides. Sequence analysis of peptides was done primarily by solid-phase Edman degradation.
Elongation factor Tu
is a single chain polypeptide composed of 393 amino acids (Mr = 43,225). Its NH2 terminus is blocked with an acetyl group, as determined by mass spectroscopy, and lysine 56 is partially methylated. The cysteine residues associated with aminoacyl tRNA and guanosine nucleotide binding are located at positions 81 and 137, respectively. Although elongation factor Tu is coded for by two genes, the only site of microheterogeneity found was at the carboxyl terminus (residue 393), which is either glycine or serine. Comparison of the first 140 amino acids of elongation factor Tu and of elongation factor G shows a strong (31%) sequence homology. In addition, secondary structure calculations predict remarkable conformational similarities between the two proteins. The NH2-terminal region of elongation factor Tu appears to be composed of two beta-sheet domains connected by an exposed, alpha-helical bridge, which includes a 14-amino acid segment released by limited treatment with
trypsin
. Structural features of the aminoacyl-tRNA binding site are discussed in the light of sequence and other chemical and biochemical data.
...
PMID:The amino acid sequence of elongation factor Tu of Escherichia coli. The complete sequence. 702 45